News

Selectivity was tested by evaluating the interaction between tyramine and rasagiline in healthy subjects. This double blind placebo controlled study was conducted in order to comply with the

Anders Ekblom is appointed to the role of executive vice president of development, effective January 1, 2009, when he will also join AstraZeneca’s senior executive team. Mr Ekblom

With the transaction, Galapagos has now completed the integration of BioFocus DPI’s activities worldwide. The San Diego facility currently employs 40 people and provides medicinal chemistry and custom

In the study, 118 patients were randomized on a 1:1 basis to receive naproxcinod or naproxen, with escalating doses every three weeks. The trial included three doses of

According to the company, the new and improved microarrays allow researchers to perform their own capture experiment and perform sequencing of enriched regions using next-generation technology such as

A linear accelerator is a key component in radiation therapy systems used to create high-energy x-rays for cancer treatments. The linear accelerators designed, developed and manufactured by Twin

Restorelle Y is said to be constructed with a physiologically compatible mesh material – Smartmesh technology – which was designed by surgeons specifically for the female anatomy and

As part of the agreement, Inlight president and co-founder Shlomo Assa will join the Syneron management team. Mr Assa brings deep experience in the laser device industry, previously

The CYP2C9 gene is important in its involvement in the metabolism of 10% of all drugs, including non-steroidal anti-inflammatory drugs (eg celecoxib, ibuprofen), anti-coagulants (eg warfarin), anti-epileptic agents